David Ami - Macrocure Chairman of the Board and Co-Founder
Chairman
Mr. David Ben Ami serves as Chairman of the Board and CoFounder of MacroCure, Ltd. He has more than 20 years of experience with activities in management, business development and corporate strategy, in the life sciences industry. He CoFounded MacroCure in early 2008. He was previously Chief Executive Officer of NVR Labs, Country Director of Boston Scientific Israel, and Director of Business Development of Teva Israel. He serves as a board member in BioCell Ltd., and Degania Silicone Ltd among other devide and pharma companies. He received his MBA degree and Bachelor of Arts in Economics and Management from TelAviv University.
Professional Marks | MBA |
Phone | 972 3 923 5556 |
Web | http://www.macrocure.com |
Macrocure Management Efficiency
The company has return on total asset (ROA) of (0.193) % which means that it has lost $0.193 on every $100 spent on assets. This is way below average. Macrocure's management efficiency ratios could be used to measure how well Macrocure manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 6 records | CHAIRMAN Age | ||
John Guerin | Daily Journal Corp | 88 | |
Charles Munger | Daily Journal Corp | 94 | |
Tim Score | Pearson PLC ADR | 60 | |
Peng Ou | Sunlands Technology Group | 46 | |
Sidney Taurel | Pearson PLC ADR | 72 | |
Xiaoming Hu | Kandi Technologies Group | 67 |
Management Performance
Return On Asset | -0.19 |
Macrocure Leadership Team
Elected by the shareholders, the Macrocure's board of directors comprises two types of representatives: Macrocure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Macrocure. The board's role is to monitor Macrocure's management team and ensure that shareholders' interests are well served. Macrocure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Macrocure's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lewis Gryziewicz, Vice President - Regulatory Affairs | ||
Danna Moran, Marketing and Sales Manager | ||
Alan Smith, Head - North American Operations | ||
Nissim Mashiach, Pres and CEO | ||
Ramesh Tharuvai, VP of Operations | ||
David Ami, Chairman of the Board and Co-Founder | ||
Mark Page, CFO |
Macrocure Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Macrocure a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -0.19 | |||
Current Valuation | 9.79 M | |||
Shares Outstanding | 16.26 M | |||
Number Of Shares Shorted | 76.85 K | |||
Price To Earning | (1.09) X | |||
Price To Book | 1.06 X | |||
Net Income | (21.1 M) | |||
Cash And Equivalents | 20.97 M | |||
Cash Per Share | 1.44 X | |||
Debt To Equity | 0.05 % |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Macrocure Stock
If you are still planning to invest in Macrocure check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Macrocure's history and understand the potential risks before investing.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |